Add To Cart

Section 1
Neurodevelopmental Disorders

Question 1 | Test | Table of Contents

New York State Office of Mental Health 

If you wish to increase the text size of this publication, maximize your window.
Click outside the box below, press Ctrl “+” several times, then scroll.
Questions? Email: info@mentalhealthce.com

Varley, Christopher K. Overview of DSM-5 Changes. Seattle Childrens, New York State Office of Mental Health, p. 12-16.

Update
The role of cannabinoids in neurodevelopmental
disorders of children and adolescents

Dias-de Freitas, F., Pimenta, S., Soares, S., Gonzaga, D., Vaz-Matos, I., & Prior, C. (2022). The role of cannabinoids in neurodevelopmental disorders of children and adolescents. El papel de los cannabinoides en los trastornos del neurodesarrollo de niños y adolescentes. Revista de neurologia, 75(7), 189–197. https://doi.org/10.33588/rn.7507.2022123
Reviewed 2023

Peer-Reviewed Journal Article References:
Ungar, W. J., Tsiplova, K., Millar, N., & Smith, I. M. (2018). Development of the Resource Use Questionnaire (RUQ–P) for families with preschool children with neurodevelopmental disorders: Validation in children with autism spectrum disorder. Clinical Practice in Pediatric Psychology, 6(2), 164–178.

Quilty, L. C., Bagby, R. M., Krueger, R. F., & Pollock, B. G. (2021). Validation of DSM–5 clinician-rated measures of personality pathology. Psychological Assessment, 33(1), 84–89.

van Dijk, I., Krueger, R. F., & Laceulle, O. M. (2021). DSM–5 alternative personality disorder model traits as extreme variants of five-factor model traits in adolescents. Personality Disorders: Theory, Research, and Treatment, 12(1), 59–69.

QUESTION 1
What are the DSM5 communication disorders? To select and enter your answer go to Test
.


Test
Section 2
Table of Contents
Top